Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sympathetic Mapping and Ablation of Renal Nerves to Treat Uncontrolled Hypertension in Real World

NCT06780696 is registered in ClinicalTrials.gov with SyMap Medical (Suzhou), Ltd. as lead sponsor.

NCT NCT06780696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06780696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sympathetic Mapping and Ablation of Renal Nerves to Treat Uncontrolled Hypertension in Real World
Lead sponsor
SyMap Medical (Suzhou), Ltd.
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
April 30, 2029
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, reduce antihypertensive drug burden, resistant hypertension, uncontrolled hypertension